United Therapeutics price target lowered to $314 from $328 at BofA
BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...
Business Insider1mon
United Therapeutics (UTHR) Gets a Buy from Wells Fargo
In a report released yesterday, Tiago Fauth from Wells Fargo maintained a Buy rating on United Therapeutics (UTHR – Research Report), with a price target of $395.00. The company’s shares ...